Építés alatt – nem éles oldal
Belépés
Befejeződött1. fázis

Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use

A legfontosabb adatok

Ki végzi
Yale University
Hol
New Haven (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Fázis
1. fázis
Résztvevők
19 fő vett részt
Kezdés
2024. ápr. 1.
Befejezés
2025. nov. 30.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • Varenicline
  • Counseling
  • Guided Self-Change Booklets
A regiszteradat frissítve
2026. november 5.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 12 feltétel megnézéseKevesebb

Ki vehet részt

  • English literate
  • Report cigarette smoking, and e-cigarette use for at least the past 3 months
  • Smoke 5 or more cigarettes per day
  • Report e-cigarette use for at least 14 days in the past month
  • Interested in quitting both products in the next month and willing to set a quit date

Ki nem vehet részt

  • Investigators will exclude anyone currently using any smoking cessation services and/or FDA pharmacotherapies
  • Investigators will exclude individuals with medical contraindications for varenicline use (i.e., severe renal impairment and unstable cardiac history)
  • Medical Conditions: Investigators will not enroll anyone with a current, serious uncontrolled medical/psychiatric condition (e.g., a condition that required a hospitalization or intensive outpatient treatment in the past year) based on review by Study Physician that would increase risk of severe adverse events and/or interfere with study participation
  • Verification of Non-Pregnancy: Females ages <55 will be given a commercially available pregnancy test to verify non-pregnancy. A female of child-bearing age that is currently pregnant or breastfeeding or report an unwillingness to use effective birth control (i.e., abstinence, IUD, implant, sterilization, pill, patch, ring, or barrier method such as condoms with spermicide) for the duration of the study will not be enrolled
  • Vulnerable Populations: Investigators will not be enrolling vulnerable populations, specifically pregnant women, children, prisoners, or institutionalized individuals
  • Investigators also will not enroll participants incapable of providing their own consent. The rationale will be provided to the individual as well as his or her family members. Referrals for further evaluation, including urgent or emergent evaluation, will be made as needed and clinically warranted
  • Individuals using other tobacco or nicotine products besides cigarettes and e-cigarettes > once per week in the last 30 days will be excluded

Helyszínek itt: Egyesült Államok

  • Yale UniversityNew Haven, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this research study is to understand whether concurrent treatment for cigarettes and e-cigarettes in which an individual quits both products at the same time (QUIT-C) or sequential treatment in which an individual quits cigarettes first followed by e-cigarettes is more effective for quitting both products. The study will also compare the effect of treatment on health-related biomarkers. All participants will receive varenicline, a medication used to treat tobacco use dependence, counseling, and cessation resources (i.e., links to text-based support, self-change booklet). Varenicline helps to reduce cravings for tobacco use and decreases the pleasurable effects of cigarettes and other tobacco products.

A vizsgálat 2 csoportja

  • QUIT-C (Concurrent)A vizsgált kezelés

    Treatment in this arm will emphasize concurrent cessation of cigarettes and e-cigarettes. All participants will receive 12-weeks of varenicline, weekly individual counseling, and access to cessation resources including a guided self-change booklet and links to free text-based support. Counseling and cessation resources will emphasize concurrent cessation.

    Kezelés: Varenicline, Counseling és Guided Self-Change Booklets

  • QUIT-S (Sequential)A vizsgált kezelés

    Treatment in this arm will focus on cessation of cigarettes followed sequentially by cessation of e-cigarettes. All participants will receive 12-weeks of varenicline, weekly individual counseling, and access to cessation resources including a guided self-change booklet and links to free text-based support. Counseling and cessation resources will emphasize sequential cessation.

    Kezelés: Varenicline, Counseling és Guided Self-Change Booklets

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Preliminary Test of Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use on Behavior, Tobacco Toxicant Exposure, and Health Effects
A regiszteradat frissítve
2026. november 5.